Descripción:

E1105 Material Submission Form NCT00520975 First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=17221122-2E12-611D-E044-0003BA3F9857

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=17221122-2E12-611D-E044-0003BA3F9857
Palabras clave:
  1. 26/8/12 26/8/12 -
  2. 9/1/15 9/1/15 - Martin Dugas
  3. 9/1/15 9/1/15 - Martin Dugas
  4. 3/7/15 3/7/15 -
Subido en:

3 de julio de 2015

DOI:
Para solicitar uno, por favor iniciar sesión.
Licencia :
Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

E1105 Material Submission Form NCT00520975

Complete the indicated sections of this form. All samples must be listed, thus multiple forms may be completed per patient. Submit the forms WITH the material(s) to the central laboratory indicated in the protocol.

Header
Reporting Period
Completed By Submitting Institutions
Shipped to
Informed consent signed?
Sample submission
Timing of material collection
Completed By Central Lab
Condition of Specimen (s)
Contacts
Comments

Similar models

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial